DE69920205D1 - Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen - Google Patents

Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen

Info

Publication number
DE69920205D1
DE69920205D1 DE69920205T DE69920205T DE69920205D1 DE 69920205 D1 DE69920205 D1 DE 69920205D1 DE 69920205 T DE69920205 T DE 69920205T DE 69920205 T DE69920205 T DE 69920205T DE 69920205 D1 DE69920205 D1 DE 69920205D1
Authority
DE
Germany
Prior art keywords
hair
induct
slow down
proteinase inhibitors
stimulate growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69920205T
Other languages
English (en)
Other versions
DE69920205T2 (de
Inventor
Francoise Jarrousse
Yann Mahe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
L'Oréal SA
Original Assignee
L'Oréal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'Oréal SA filed Critical L'Oréal SA
Application granted granted Critical
Publication of DE69920205D1 publication Critical patent/DE69920205D1/de
Publication of DE69920205T2 publication Critical patent/DE69920205T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69920205T 1998-05-12 1999-05-11 Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen Expired - Fee Related DE69920205T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9805968 1998-05-12
FR9805968A FR2778558B1 (fr) 1998-05-12 1998-05-12 Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
PCT/FR1999/001124 WO1999058101A1 (fr) 1998-05-12 1999-05-11 Utilisation d'inhibiteurs de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute

Publications (2)

Publication Number Publication Date
DE69920205D1 true DE69920205D1 (de) 2004-10-21
DE69920205T2 DE69920205T2 (de) 2005-09-22

Family

ID=9526261

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920205T Expired - Fee Related DE69920205T2 (de) 1998-05-12 1999-05-11 Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen

Country Status (10)

Country Link
US (3) US6645477B1 (de)
EP (1) EP1076549B1 (de)
JP (1) JP3891541B2 (de)
AT (1) ATE275919T1 (de)
AU (1) AU3611299A (de)
CA (1) CA2330807C (de)
DE (1) DE69920205T2 (de)
ES (1) ES2229701T3 (de)
FR (1) FR2778558B1 (de)
WO (1) WO1999058101A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778558B1 (fr) * 1998-05-12 2001-02-16 Oreal Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
US6803044B1 (en) 1999-03-24 2004-10-12 Zengen, Inc. Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus
US6887846B2 (en) 1999-03-24 2005-05-03 Zengen, Inc. Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
US6800291B1 (en) 1999-03-24 2004-10-05 Zengen, Inc. Uro-genital condition treatment system
US7402559B2 (en) 1999-03-24 2008-07-22 Msh Pharma, Incorporated Composition and method of treatment for urogenital conditions
DE10102784A1 (de) * 2001-01-22 2002-08-01 Henkel Kgaa Kosmetische oder pharmazeutische Zubereitungen zur Behandlung epithelialen Deckgewebes
US6780838B2 (en) 2001-01-29 2004-08-24 Zengen, Inc. Compounds for treating fungal pathologies of the oral cavity
US6894028B2 (en) 2001-04-06 2005-05-17 Zengen, Inc. Use of KPV tripeptide for dermatological disorders
US7115574B2 (en) 2001-12-10 2006-10-03 Zengen, Inc. System and method for support legacy operating system booting in a legacy-free system
US6939846B2 (en) 2001-12-17 2005-09-06 Zengen, Inc. Use of a polypeptide for treatment of pruritis in animals
US7834210B2 (en) * 2006-08-04 2010-11-16 Bioderm Research Hair loss prevention by natural amino acid and peptide complexes
US20050180940A1 (en) * 2004-02-17 2005-08-18 Puma Jeffrey P. Protect against hair loss
JP2010504974A (ja) * 2006-09-28 2010-02-18 フォリカ，インコーポレーテッド 新しい毛嚢を生成させ毛髪を成長させる方法、キット、及び組成物
ES2330291B1 (es) 2008-02-29 2010-10-18 Lipotec Sa Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
ES2349972B1 (es) 2009-02-16 2011-11-24 Lipotec, S.A. Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas.
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
US10702544B2 (en) * 2016-01-12 2020-07-07 National University Corporation Tokyo Medical And Dental University Composition for ameliorating loss of hair and graying of hair, and use thereof
BR112019000706A8 (pt) 2016-07-15 2022-12-06 Pasteur Institut Agente de estímulo do receptor 1b de 5-hidroxitriptamina para reparo de pele e/ou cabelo
KR102567042B1 (ko) * 2022-12-16 2023-08-16 (주)에이피테크놀로지 2'-푸코실락토오스를 유효성분으로 포함하는 모발성장 촉진용 및 탈모개선, 예방 또는 치료용 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1717019B1 (de) * 1958-12-05 1972-04-27 Henkel & Cie Gmbh Verfahren zur Herstellung von hochdispersen Schwefel enthaltenden grenzflaechenaktiven fluessigen Produkten
US4814351A (en) * 1987-06-26 1989-03-21 Redken Laboratories, Inc. Scalp treatment
GB8806893D0 (en) * 1988-03-23 1988-04-27 Unilever Plc Cosmetic composition
JPH0374318A (ja) 1989-08-10 1991-03-28 Katsumi Mizumaki 育毛・養毛料
FR2651125B1 (fr) * 1989-08-23 1992-10-02 Roussel Uclaf Compositions pharmaceutiques de type "pates a l'eau".
JPH04224522A (ja) 1990-04-27 1992-08-13 Merck & Co Inc 繊維芽細胞増殖因子含有組成物による禿頭症の治療又は予防方法
US5824297A (en) * 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
AU667675B2 (en) * 1991-06-28 1996-04-04 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
JPH0543424A (ja) 1991-08-14 1993-02-23 Sansho Seiyaku Co Ltd 毛髪用外用剤
JP3229643B2 (ja) 1992-03-31 2001-11-19 秀興 小川 育毛促進剤
US5618925A (en) 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6380366B1 (en) * 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
US6025334A (en) 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6028118A (en) 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
US5811395A (en) * 1995-06-07 1998-09-22 Medical University Of South Carolina Relaxin analogs and derivatives methods and uses thereof
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
HUP0000505A3 (en) * 1996-08-28 2001-12-28 Procter & Gamble Saturated 7-9 membered heterocyclic n-hydroxycarboxamide derivatives and pharmaceutical compositions containing them
JPH10279501A (ja) * 1997-02-10 1998-10-20 Rohto Pharmaceut Co Ltd 育毛剤
JP3464591B2 (ja) 1997-07-04 2003-11-10 カネボウ株式会社 養毛化粧料
FR2778558B1 (fr) * 1998-05-12 2001-02-16 Oreal Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute

Also Published As

Publication number Publication date
CA2330807A1 (fr) 1999-11-18
US6645477B1 (en) 2003-11-11
DE69920205T2 (de) 2005-09-22
ATE275919T1 (de) 2004-10-15
JP3891541B2 (ja) 2007-03-14
AU3611299A (en) 1999-11-29
JP2002514581A (ja) 2002-05-21
WO1999058101A1 (fr) 1999-11-18
EP1076549A1 (de) 2001-02-21
CA2330807C (fr) 2007-01-30
FR2778558B1 (fr) 2001-02-16
FR2778558A1 (fr) 1999-11-19
EP1076549B1 (de) 2004-09-15
US20040071647A1 (en) 2004-04-15
US20060105006A1 (en) 2006-05-18
ES2229701T3 (es) 2005-04-16

Similar Documents

Publication Publication Date Title
ATE275919T1 (de) Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen
ATE292462T1 (de) Behandlung von asthma anhand von mek-inhibitoren
DE69838338D1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE50002293D1 (de) Verwendung von csf-1-inhibitoren
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
MX9702487A (es) Compuestos peptidilo y su uso terapeutico como inhibidores de las metaloproteasas.
DE60036025D1 (de) Verfahren zur behandlung von hautkrebs mittels zusammensetzungen, die einen endothelinrezeptor-b-hemmer enthalten
DE60118544D1 (de) Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren
ATE235191T1 (de) Markraumnagel für die versorgung von frakturen der hüfte
DE3683318D1 (de) Verwendung von alfuzosin zur behandlung von erkrankungen der harnwege.
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DE59812454D1 (de) Vorrichtung für die hochfrequenzbehandlung von körpergewebe
DE3578611D1 (de) Instrumente zur behandlung von verformten naegeln bei menschlichen patienten.
ATE404202T1 (de) Die verwendung von potenten, selektiven und nontoxischen c-kithemmern zur behandlung von interstitieller blasenentzündung
DE60108857D1 (de) Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren
EP1123414A4 (de) Antisense modulation der expression von integrin alpha 4
ATE217514T1 (de) Verwendung von bradykininantagonisten zur induzierung oder stimulation des haarwachstums und/oder zur verlangsamung des haarausfalls
BR9808221A (pt) Método de tratamento de tumor.
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE3687097D1 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE60111620D1 (de) Aktiviertes protein c zur behandlung von pankreatitis
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
EP1056458A4 (de) Methoden zur behandlung von schmerzen, einscliesslich chronischen und frauenspezifischen schmerzen
DK0671909T3 (da) Syndecanstimulering af cellulær differentiering

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee